Navigation Links
Micromet Reports Fourth Quarter and Full Year 2009 Financial Results
Date:3/4/2010

aterially from any future results expressed or implied by any forward-looking statements include the risk that blinatumomab or our other product candidates do not demonstrate safety and/or efficacy in future clinical trials, delays in development and testing,  including the risk that we will not obtain approval to market blinatumomab, and the risks associated with reliance on outside financing to meet capital requirements. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2009, filed with the SEC on November 6, 2009, as well as other filings by the company with the SEC.

    
    
                                Micromet, Inc.
                    Condensed Consolidated Balance Sheets
                       (In thousands, except par value)
    
                                             December 31,   December 31,
                                                 2009           2008
                                             ------------   ------------
    Assets
    Current assets:
        Cash and cash equivalents                $113,434        $46,168
        Short-term investments                      4,169              -
        Accounts receivable                           464          3,424
        Prepaid expenses and other current
         assets                                     2,156          1,950
                                                    -----          -----
    Total current assets                          120,223         51,542
    Property and equipment, net                     3,959          3,322
    Goodwill                                        6,462          6,462
    Patents, net                                    1,016          5,250
    Deposits and other assets                           -            959
    Restricted cash                                 3,153         
'/>"/>
SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Data from Phase 1 Study Confirm High Response Rate of Micromets Blinatumomab in Patients with Non-Hodgkins Lymphoma
2. Micromet, Inc. Reports Second Quarter 2009 Financial Results
3. Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
4. Micromet, Inc. Reports First Quarter 2009 Financial Results
5. Micromet To Present at the ROTH 21st Annual Orange County Growth Stock Conference
6. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
7. Micromet to Present at the Piper Jaffray 20th Annual Health Care Conference
8. Micromet, Inc. Reports Second Quarter 2008 Financial Results
9. Micromet, Inc. Reports First Quarter 2008 Financial Results
10. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
11. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... (Sept. 19, 2014) Instituting a partial smoking ban ... in expired carbon monoxide levels, an indicator of exposure ... shelter residents, health, according to new research. The University ... the study results last week in the journal ... the United States has fallen to 18 percent among ...
(Date:9/21/2014)... Ohio (PRWEB) September 21, 2014 More than a ... and most dryer fires start in one of two ways. ... isn’t cleaned out properly. The second type of dryer fire ... fire. (Dryers can also catch fire due to malfunctioning electrical ... a repairman to take a look!) Here are some ways ...
(Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... companies that help businesses and manufacturers perform tests on ... materials. In an increasingly regulated society, pressure on operators ... is higher than ever. A greater number of government ... testing of manufacturers' goods prior to sale. Although revenue ...
(Date:9/21/2014)... Think of Sparta. , Ancient Greek warriors were fed ... demands of battle on distant fields. Cancer cells that ... new study revealing previously unknown differences between cancer cells ... and those that travel to other organs. , Given ... the primary cause of cancer-related death, understanding how they ...
(Date:9/21/2014)... 2014 (HealthDay News) -- Young women starting college understand ... foods they should eat. But they aren,t confident they ... to a new study. The study involved ... Illinois,s Peer Education Exercising and Eating Right program. The ... choose to eat if they were very busy with ...
Breaking Medicine News(10 mins):Health News:UTHealth researchers study impact of smoking ban in homeless shelter 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News: College Women Can Use Food Strategies, Study Finds 2
... medicine, gains in cancer survival over the long term ... less stringent evidence criteria, a researcher told the 2011 ... The introduction of targeted treatments means the traditional ... way of getting new treatments to cancer patients who ...
... By Denise Mann HealthDay Reporter , FRIDAY, ... a glass or two of red wine a day is ... the anti-hypertensive effects of antioxidants found in red wine called ... polyphenols, at least in isolation, may not lower ...
... Men with prostate cancer that has spread to other ... hormone therapy suffer less from fatigue if they are ... according to results from a phase III clinical trial ... European Multidisciplinary Cancer Congress [1], in Stockholm today (Monday ...
... Stockholm, Sweden: New research has found that breast cancer ... disease, whereas the decision about the most effective treatment ... biopsy of the primary tumour. For some patients, biopsy ... it may completely change their clinical management, a Swedish ...
... The Netherlands: Belly fat, known clinically as central obesity, has ... study. The findings, which will be presented at the ... 2011), have shown central obesity as a risk factor for ... a number of health effects, such as diabetes and heart ...
... Amsterdam, The Netherlands: A new type of diagnostic imaging ... those which are cancerous - could be used to ... the disease. A study by Belgian researchers, ... the European Respiratory Society,s Annual Congress in Amsterdam, found ...
Cached Medicine News:Health News:Smaller, faster trials can improve cancer patient survival 2Health News:Smaller, faster trials can improve cancer patient survival 3Health News:Antioxidants Not Behind Red Wine's Healthy Effect on Heart: Study 2Health News:Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial 2Health News:Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial 3Health News:Breast cancer tumor make-up changes through the course of disease 2Health News:Breast cancer tumor make-up changes through the course of disease 3Health News:'Belly fat' linked to development of asthma 2Health News:New diagnostic imaging for lung cancer could prevent unnecessary surgery 2
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
(Date:9/19/2014)... -- Merck (NYSE: MRK ), known as MSD outside ... , is teaming with celebrity chef and cookbook author Leticia ... an educational program encouraging Hispanics with type 2 diabetes to achieve ... to help reduce the risk of serious health problems. Hispanics in ... risk for developing type 2 diabetes than non-Hispanic white adults, and ...
(Date:9/19/2014)... 2014 Five MinuteClinic walk-in medical clinics are opening inside ... area. Three clinics opened in Memphis and ... will be added in Springfield on September ... is expected to open October 22.  MinuteClinic is the largest and ... United States . The Memphis ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... June 4 Mach 7 Technologies (M7T), a global ... global headquarters from suburban Chicago to greater Burlington, ... for Americas, sales and professional service operations, and finance and administration. ... functions. , , , ...
... LAIYANG, China , June 4 /PRNewswire-Asia-FirstCall/ ... company with its principal operations in China , today,announced that the ... Market. , , , ... Jiangbo anticipates that its common stock will begin trading on the ...
Cached Medicine Technology:Mach 7 Technologies Establishes New Headquarters in Burlington, VT 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 2Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market 3
... powerful, lightweight, easy to ... durable foam silicone rubber ... by machine washable cotton ... easily adjusts to all ...
... powerful, lightweight, easy to ... durable foam silicone rubber ... by machine washable cotton ... easily adjusts to all ...
Xenon surgical headlight system is durable, comfortable, lightweight and deliver dependable bright light through a patented shielded fiber optic bundle. It is easy to wear....
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
Medicine Products: